Tapewire

Nasdaq · USD

ARQT

Arcutis Biotherapeutics, Inc.

Export transactions ↓
Tapewire entity
4236
SEC CIK
0001787306
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 76 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025019
Dec 202505
Jan 202602
Feb 2026011
Mar 2026013
Apr 202601
May 202608
Jun 202603
Jul 202601
Aug 2026010
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 12, 2020 Filed Nov 13, 2020 16:57 UTC Exercise / conversionCommon Stock 1,222 $0.58 $709.00
Disclosure

SEC source: 0001567619-20-019438 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 21:34 UTC GrantStock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $18.72 $0.00
Disclosure

SEC source: 0001567619-20-018694 · doc1.xml · derivative · entry 1

Curran Terrie · CIK 0001690298 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2030-11-02

F1 · derivative.exercise_date: The option vests as to 1/3 of the total shares on each of November 2, 2021, November 2, 2022 and November 2, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 21:33 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,809 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-018692 · doc1.xml · derivative · entry 6

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,772

Underlying: Common Stock · 1,809 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 21:33 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 391 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-018692 · doc1.xml · derivative · entry 5

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,057

Underlying: Common Stock · 391 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 21:33 UTC SaleCommon Stock 2,200 $18.27 $40,186.08
Disclosure

SEC source: 0001567619-20-018692 · doc1.xml · nonDerivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,622

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $18.02 to $18.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 21:33 UTC Exercise / conversionCommon Stock 1,809 $1.68 $3,039.12
Disclosure

SEC source: 0001567619-20-018692 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 21:33 UTC Exercise / conversionCommon Stock 391 $1.68 $656.88
Disclosure

SEC source: 0001567619-20-018692 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
October 26, 2020 Filed Oct 27, 2020 18:03 UTC
Lock Kenneth A.Chief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,668 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001567619-20-018207 · doc1.xml · derivative · entry 2

Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,080

Underlying: Common Stock · 2,668 shares

Expires 2029-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F3 · derivative.exercise_date: The option began vesting as to 1/4 of the total shares on October 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on October 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
October 26, 2020 Filed Oct 27, 2020 18:03 UTC
Lock Kenneth A.Chief Commercial Officer
Exercise / conversionCommon Stock 2,668 $6.52 $17,395.36
Disclosure

SEC source: 0001567619-20-018207 · doc1.xml · nonDerivative · entry 1

Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
October 22, 2020 Filed Oct 23, 2020 17:27 UTC
Lock Kenneth A.Chief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,695 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001567619-20-018132 · doc1.xml · derivative · entry 2

Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,748

Underlying: Common Stock · 2,695 shares

Expires 2029-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F3 · derivative.exercise_date: The option began vesting as to 1/4 of the total shares on October 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on October 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
October 22, 2020 Filed Oct 23, 2020 17:27 UTC
Lock Kenneth A.Chief Commercial Officer
Exercise / conversionCommon Stock 2,695 $6.52 $17,571.40
Disclosure

SEC source: 0001567619-20-018132 · doc1.xml · nonDerivative · entry 1

Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
October 15, 2020 Filed Oct 16, 2020 18:06 UTC
Lock Kenneth A.Chief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001567619-20-017916 · doc1.xml · derivative · entry 2

Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,443

Underlying: Common Stock · 7,500 shares

Expires 2029-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F3 · derivative.exercise_date: The option began vesting as to 1/4 of the total shares on October 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on October 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
October 15, 2020 Filed Oct 16, 2020 18:06 UTC
Lock Kenneth A.Chief Commercial Officer
Exercise / conversionCommon Stock 7,500 $6.52 $48,900.00
Disclosure

SEC source: 0001567619-20-017916 · doc1.xml · nonDerivative · entry 1

Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
October 15, 2020 Filed Oct 16, 2020 18:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,222 $0.00 Strike: $0.58 $0.00
Disclosure

SEC source: 0001567619-20-017915 · doc1.xml · derivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,106

Underlying: Common Stock · 1,222 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F3 · derivative.exercise_date: The option began vesting monthly over 35 months beginning July 11, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
October 15, 2020 Filed Oct 16, 2020 18:06 UTC Exercise / conversionCommon Stock 1,222 $0.58 $709.00
Disclosure

SEC source: 0001567619-20-017915 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,622

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 21:27 UTC
ORBIMED ADVISORS LLCDirector · 10% owner
ORBIMED CAPITAL LLCDirector · 10% owner
OrbiMed Capital GP VII LLCDirector · 10% owner
PurchaseCommon Stock 296,000 $25.00 $7,400,000.00
Disclosure

SEC source: 0000947871-20-000782 · ownership.xml · nonDerivative · entry 2

ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner

ORBIMED CAPITAL LLC · CIK 0001157524 · Director · 10% owner

OrbiMed Capital GP VII LLC · CIK 0001760648 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 902,286

F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended.

F3 · ownership.nature: This report on Form 4 is filed by OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. The Reporting Persons have designated Jonathan Silverstein to serve on the Issuer's board of directors.

F4 · ownership.nature: The Shares are held of record by OrbiMed Partners Master Fund Limited ("OPM"). OrbiMed Capital is the investment manager of OPM and is a relying advisor of OrbiMed Advisors. OrbiMed Advisors and OrbiMed Capital exercise voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the Shares held by OPM.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 21:27 UTC
ORBIMED ADVISORS LLCDirector · 10% owner
ORBIMED CAPITAL LLCDirector · 10% owner
OrbiMed Capital GP VII LLCDirector · 10% owner
PurchaseCommon Stock 200,000 $25.00 $5,000,000.00
Disclosure

SEC source: 0000947871-20-000782 · ownership.xml · nonDerivative · entry 1

ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner

ORBIMED CAPITAL LLC · CIK 0001157524 · Director · 10% owner

OrbiMed Capital GP VII LLC · CIK 0001760648 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 4,267,564

F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended.

F2 · ownership.nature: The Shares are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP VII") is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of OrbiMed GP VII. OrbiMed GP VII and OrbiMed Advisors may be deemed to have voting and investment power over the securities held by OPI VII and may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the Shares held by OPI VII.

F3 · ownership.nature: This report on Form 4 is filed by OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. The Reporting Persons have designated Jonathan Silverstein to serve on the Issuer's board of directors.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 17:23 UTC
SILVERSTEIN JONATHANDirector · 10% owner
PurchaseCommon Stock 296,000 $25.00 $7,400,000.00
Disclosure

SEC source: 0000947871-20-000781 · ownership.xml · nonDerivative · entry 2

SILVERSTEIN JONATHAN · CIK 0001171005 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 902,286

F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended.

F3 · ownership.nature: The Reporting Person is the designated representative of OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital") on the Issuer's board of directors. Each of OrbiMed GP VII, OrbiMed Advisors, OrbiMed Capital LLC, and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

F4 · ownership.nature: The Shares are held of record by OrbiMed Partners Master Fund Limited ("OPM"). OrbiMed Capital is the investment manager of OPM and is a relying adviser of OrbiMed Advisors. OrbiMed Advisors and OrbiMed Capital exercise voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and the Reporting Person, each of whom disclaims beneficial ownership of the Shares held by OPM.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 17:23 UTC
SILVERSTEIN JONATHANDirector · 10% owner
PurchaseCommon Stock 200,000 $25.00 $5,000,000.00
Disclosure

SEC source: 0000947871-20-000781 · ownership.xml · nonDerivative · entry 1

SILVERSTEIN JONATHAN · CIK 0001171005 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 4,267,564

F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended.

F2 · ownership.nature: The Shares are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP VII"), is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of OrbiMed GP VII. OrbiMed GP VII and OrbiMed Advisors may be deemed to have voting and investment power over the securities held by OPI VII and may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and the Reporting Person, each of whom disclaims beneficial ownership of the Shares held by OPI VII.

F3 · ownership.nature: The Reporting Person is the designated representative of OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital") on the Issuer's board of directors. Each of OrbiMed GP VII, OrbiMed Advisors, OrbiMed Capital LLC, and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
October 01, 2020 Filed Oct 6, 2020 01:13 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 390 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-017606 · doc1.xml · derivative · entry 7

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,448

Underlying: Common Stock · 390 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
October 01, 2020 Filed Oct 6, 2020 01:13 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,810 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-017606 · doc1.xml · derivative · entry 6

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,581

Underlying: Common Stock · 1,810 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
October 01, 2020 Filed Oct 6, 2020 01:13 UTC SaleCommon Stock 390 $25.18 $9,820.71
Disclosure

SEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,400

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $27.68 to $28.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 01, 2020 Filed Oct 6, 2020 01:13 UTC Exercise / conversionCommon Stock 390 $1.68 $655.20
Disclosure

SEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
October 01, 2020 Filed Oct 6, 2020 01:13 UTC SaleCommon Stock 1,810 $28.18 $51,008.15
Disclosure

SEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,400

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $27.68 to $28.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 01, 2020 Filed Oct 6, 2020 01:13 UTC Exercise / conversionCommon Stock 1,810 $1.68 $3,040.80
Disclosure

SEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 29, 2020 Filed Oct 1, 2020 21:01 UTC
OSBORNE DAVID WChief Technical Officer
SaleCommon Stock 15,000 $30.00 $450,000.00
Disclosure

SEC source: 0001567619-20-017382 · doc1.xml · nonDerivative · entry 1

OSBORNE DAVID W · CIK 0001252999 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,279

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
September 29, 2020 Filed Oct 2, 2020 01:00 UTC
Smither John WChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 500 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-017381 · doc1.xml · derivative · entry 4

Smither John W · CIK 0001559583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,482

Underlying: Common Stock · 500 shares

Expires 2029-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
September 29, 2020 Filed Oct 2, 2020 01:00 UTC
Smither John WChief Financial Officer
SaleCommon Stock 1,250 $30.00 $37,500.00
Disclosure

SEC source: 0001567619-20-017381 · doc1.xml · nonDerivative · entry 3

Smither John W · CIK 0001559583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 98,715

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · ownership.nature: The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
September 29, 2020 Filed Oct 2, 2020 01:00 UTC
Smither John WChief Financial Officer
SaleCommon Stock 500 $30.00 $15,000.00
Disclosure

SEC source: 0001567619-20-017381 · doc1.xml · nonDerivative · entry 2

Smither John W · CIK 0001559583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,875

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
September 29, 2020 Filed Oct 2, 2020 01:00 UTC
Smither John WChief Financial Officer
Exercise / conversionCommon Stock 500 $1.68 $840.30
Disclosure

SEC source: 0001567619-20-017381 · doc1.xml · nonDerivative · entry 1

Smither John W · CIK 0001559583 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
September 29, 2020 Filed Oct 2, 2020 01:02 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-017383 · doc1.xml · derivative · entry 7

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,492

Underlying: Common Stock · 3,000 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
September 29, 2020 Filed Oct 2, 2020 01:02 UTC
Watanabe ToddDirector · President and CEO
SaleCommon Stock 3,000 $30.00 $90,000.00
Disclosure

SEC source: 0001567619-20-017383 · doc1.xml · nonDerivative · entry 2

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 566,928

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 29, 2020 Filed Oct 2, 2020 01:02 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionCommon Stock 3,000 $1.68 $5,041.80
Disclosure

SEC source: 0001567619-20-017383 · doc1.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 569,928

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 29, 2020 Filed Jan 7, 2021 19:39 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-000711 · doc1.xml · derivative · entry 7

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,492

Underlying: Common Stock · 3,000 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
September 29, 2020 Filed Jan 7, 2021 19:39 UTC
Watanabe ToddDirector · President and CEO
SaleCommon Stock 3,000 $30.00 $90,000.00
Disclosure

SEC source: 0001567619-21-000711 · doc1.xml · nonDerivative · entry 2

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 566,928

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 29, 2020 Filed Jan 7, 2021 19:39 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionCommon Stock 3,000 $1.68 $5,041.80
Disclosure

SEC source: 0001567619-21-000711 · doc1.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 569,928

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 15, 2020 Filed Sep 16, 2020 21:57 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,222 $0.00 Strike: $0.58 $0.00
Disclosure

SEC source: 0001567619-20-016809 · doc1.xml · derivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,328

Underlying: Common Stock · 1,222 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F3 · derivative.exercise_date: The option began vesting monthly over 35 months beginning July 11, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
September 15, 2020 Filed Sep 16, 2020 21:57 UTC Exercise / conversionCommon Stock 1,222 $0.58 $709.00
Disclosure

SEC source: 0001567619-20-016809 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 15:48 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,200 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-016301 · doc1.xml · derivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,810

Underlying: Common Stock · 2,200 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 15:48 UTC SaleCommon Stock 2,200 $24.38 $53,643.26
Disclosure

SEC source: 0001567619-20-016301 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,178

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $24.00 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 15:48 UTC Exercise / conversionCommon Stock 2,200 $1.68 $3,696.00
Disclosure

SEC source: 0001567619-20-016301 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,378

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment Exercise / conversionStock Option (Right to Buy) · Derivative 1,172 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-017605 · doc1.xml · derivative · entry 7

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,838

Underlying: Common Stock · 1,172 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment Exercise / conversionStock Option (Right to Buy) · Derivative 1,028 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-017605 · doc1.xml · derivative · entry 6

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,391

Underlying: Common Stock · 1,028 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment SaleCommon Stock 1,172 $24.38 $28,577.23
Disclosure

SEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,178

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $24.00 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment Exercise / conversionCommon Stock 1,172 $1.68 $1,968.96
Disclosure

SEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment SaleCommon Stock 1,028 $24.38 $25,066.03
Disclosure

SEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,178

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $24.00 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment Exercise / conversionCommon Stock 1,028 $1.68 $1,727.04
Disclosure

SEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
August 20, 2020 Filed Aug 21, 2020 18:19 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-015854 · doc1.xml · derivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,982

Underlying: Common Stock · 5,000 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F3 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
August 20, 2020 Filed Aug 21, 2020 18:19 UTC Exercise / conversionCommon Stock 5,000 $1.68 $8,400.00
Disclosure

SEC source: 0001567619-20-015854 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

Read SEC document
August 18, 2020 Filed Aug 19, 2020 21:48 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,076 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-20-015772 · doc1.xml · derivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,667

Underlying: Common Stock · 5,076 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F3 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.